4//SEC Filing
ALNYLAM PHARMACEUTICALS, INC. 4
Accession 0001181431-12-051916
$ALNYCIK 0001178670operating
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 6:14 PM ET
Size
6.7 KB
Accession
0001181431-12-051916
Insider Transaction Report
Form 4
NOVARTIS AG
10% Owner
Transactions
- Sale
Common Stock
2012-09-20$19.42/sh−1,551,896$30,137,820→ 4,051,002 total(indirect: See footnote)
NOVARTIS PHARMA AG
10% Owner
Transactions
- Sale
Common Stock
2012-09-20$19.42/sh−1,551,896$30,137,820→ 4,051,002 total(indirect: See footnote)
Footnotes (1)
- [F1]These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeoperating
Related Parties
1- filerCIK 0001178670
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 6:14 PM ET
- Size
- 6.7 KB